INTRODUCTION
Macrophages, which are specialized for phagocytosis, are an essential component of the innate immune system. Recent discoveries reveal that macrophage functions are not restricted to host defense and the clearance of apoptotic cells, but also extend to tissue development, homeostasis, and repair. 1 Macrophages can be generated from the yolk sac, from fetal liver, and through hematopoietic stem cell-derived hematopoiesis in the bone marrow. Most tissue macrophages are derived from embryonic precursors that are seeded in the tissues before birth and are maintained by self-renewal after birth, whereas macrophages in the heart, dermis, and gut are continuously replaced by monocyte precursors in adulthood. [2] [3] [4] In addition, macrophages acquire tissue-specific characteristics through transcriptional and epigenetic regulation by environmental factors in the local tissue. 5 For example, retinoic acid in the omentum, transforming growth factor-b in the brain, and heme in the spleen induce GATA6 in peritoneal macrophages, Sall1 in microglia, and Spi-C in red-pulp macrophages, respectively. [6] [7] [8] Immune responses in the colon must be tightly regulated. An invasion of pathogenic microbes into the colon induces a robust protective immune response; however, a similar response mounted against commensal bacteria if the colonic epithelial barrier breaks down can lead to inflammatory bowel disease (IBD). Unlike many tissue macrophages, colonic macrophages maintain their homeostasis from a constant supply of blood monocytes that differentiate into macrophages in parallel with their fitness to respond to commensal bacteria, 9 through a process referred to as the ''monocyte waterfall.'' 10 Colonic macrophages and their precursor monocytes are crucial contributors to the development of the IBD pathology. A specific deletion of the interleukin-10 (IL-10) receptor on CX3CR1-positive macrophages causes spontaneous colitis. 11 In addition, we and another group reported that blockading the infiltration of inflammatory monocytes with an anti-CCR2 antibody or by depleting Gram-positive bacteria attenuates dextran sodium sulfate (DSS)-induced colitis. 12, 13 Asano et al. 14 showed that CD169-positive macrophages in the colon are responsible for mobilizing monocytes under inflammatory conditions. These findings suggest that monocyte recruitment into the colon is a prerequisite for the development of colitis. However, little is known about the environmental factors and molecular mechanisms that promote the differentiation of inflammatory monocytes into colitogenic macrophages in vivo.
Tumor necrosis factor-a (TNF-a) and inducible nitric oxide synthase (iNOS) are representative inflammatory mediators that contribute to the development of colitis, suggesting that a blockade of these mediators may be therapeutic. In fact, the apoptosis of intestinal epithelial cells was reduced in IL-10 À / À colitic mice treated with iNOS inhibitors and a TNFneutralizing monoclonal antibody. 15 We previously reported that accumulations of CD11b þ CD11c int/ À cells in the inflamed colon contain macrophages, monocytes, eosinophils, and neutrophils at the peak of inflammation; of these, only the monocytes and macrophages produce the colitogenic mediators TNF and iNOS. 13 Inflammation switches monocytes from differentiating into anti-inflammatory macrophages to inflammatory macrophages and dendritic cells. 12, [16] [17] [18] However, the identity and detailed differentiation mechanisms of colitogenic as well as anti-inflammatory macrophages in vivo are poorly understood. Here, using a DSS-induced colitis model, we found that the production of colitogenic mediators was confined to inflammatory monocyte and inflammatory macrophage subpopulations among CD64 þ cells, suggesting that these cells are colitogenic monocyte/macrophages. In this context, interferong (IFN-g)-dependent signal transducer and activator of transcription 1 (Stat1) activation was required for the development of colitogenic macrophages from monocytes. Importantly, the IFN-g-dependent Stat1 activation enhanced the acetylation of histone at the promoter regions of colitogenic mediators in the colitogenic monocytes/macrophages.
RESULTS

Identification of colitogenic monocyte/macrophage subpopulations
The colon lamina propria contains a variety of immune cells, including monocytes, macrophages, and dendritic cells. The ''monocyte waterfall,'' a recently proposed model for intestinal macrophage differentiation, discriminates between resident macrophages, monocyte-derived macrophages, and dendritic cells. 10, 12, 17, 18 According to this model, after gating on live Figure  S1A online (Figure 1a and Supplementary Figure S1B-D). Supporting these definitions, the cells in P1 were small in size and showed a typical monocyte-like morphology with a horseshoe-shaped nucleus, whereas those in P4 showed a resident macrophage morphology; i.e., large with an abundant foamy cytoplasm. P2 and P3 showed intermediate morphologies between P1 and P4 (Supplementary Figure  S1C) . At 4 days after DSS challenge, all of the fractions expressed high levels of the chemokine receptor CCR2 (Supplementary Figure S1C) , indicating that they were of the monocyte/macrophage lineage. Consistent with these observations, the expression level of CX3CR1, another indicator for the monocyte/macrophage lineage, was gradually increased from P1 to P4 (Supplementary Figure S1D) .
We next identified the colitogenic fraction within the P1-P4 subpopulations ( Figure 1 ). At steady state (before DSS challenge), most of the colon CD64 þ cells were P3 and P4 ( Figure 1a , left panel). In contrast, on day 6 of the DSS challenge, B60% of the colon CD64 þ cells were P1 and P2, and B36% were P3 and P4 ( Figure 1a , middle panel). The numbers of cells in P2 greatly decreased and in P3 also significantly decreased by day 10 after DSS challenge (4 days after ending the DSS treatment) (Figure 1a , right panel, and Figure 1c) , at which time the crypt structure had begun to recover (under restoration, Figure 1b) . Although each of these subpopulations increased in absolute numbers on day 6 of the DSS challenge, the largest increases were in the P1 and P2 populations, and the smallest increase was in the P4 population (Figure 1a,c) . To investigate the functional consequence of each macrophage fraction, we compared the mRNA expression of pro-and antiinflammatory mediators in each subpopulation in steady-state vs. DSS-challenged (day 6) conditions. The expressions of the transcription factor Stat1 and the proinflammatory mediators Tnf and Nos2 were enhanced in the P1 and P2 populations from DSS-challenged mice (day 6) compared with the same populations from steady-state mice, although the upregulation of Tnf in P1 was not significant (P ¼ 0.082, Figure 1d ). On the other hand, the Il6 and Il10 expressions were unaffected and remained comparable in each subpopulation between the steady-state and DSS-challenged (day 6) mice. Collectively, these results suggested that the colitogenic cells in the P1-P4 subpopulations are the inflammatory monocytes (P1) and inflammatory macrophages (P2).
Requirement of the IFN-c-Stat1 axis for colitogenic macrophage development Phosphorylated Stat1 is detected in the monocytic cells from patients with ulcerative colitis but not from those with Crohn's disease. 19 Given that the Stat1 expression was greatly enhanced in inflammatory monocytes (P1) and inflammatory macrophages (P2) but not in other populations in the colon (Figure 1d ), we next used Stat1-deficient (Stat1 À / À ) mice to test whether the transcription factor Stat1 is essential for the development of colitogenic cells. Notably, on day 6 of the DSS À / À mice was not due to the diminished mobilization of inflammatory monocytes into the inflamed colon, these results indicated that Stat1 is important for the optimal generation of inflammatory macrophages from inflammatory monocytes in the inflamed colon.
Stat1 is activated by proinflammatory cytokines such as IFNa/b, IFN-g, and IL-6. 20 As Stat1 was upregulated but the IL-6 expression was unaltered in the inflamed colon (Figure 1d ), we focused on IFNs. To determine which type of IFN activates Stat1, we used DSS to challenge mice lacking Ifnar1 (a receptor for IFN-a/b) or Ifngr1 (a receptor for IFN-g). Importantly, the generation of inflammatory macrophages (P2) was impaired in
,e and Supplementary Figure S2D ). Like the Stat1 À / À mice, the Ifngr1 À / À mice did not show any change in its baseline phenotype (Supplementary Figure S2E,F) . In this context, the DSS-challenged mice produced significantly more IFN-g in the inflamed colon and serum than did unchallenged mice (Supplementary Figure 2G) . As the distinct composition of the commensal bacteria in Ifngr1 À / À mice might affect their susceptibility to DSS-induced colitis, 21, 22 we also confirmed that the development of inflammatory macrophages was impaired in the colon of wild-type (WT) mice treated with XMG1.2, a neutralizing antibody against IFN-g (Supplementary Figure S2H,I ). Collectively, these results suggested that the IFN-g-dependent activation of Stat1 plays a critical role in generating the colitogenic inflammatory macrophages from inflammatory monocytes.
Milder colitis development in Stat1
À / À mice Stat1 À / À mice were assessed histologically to determine whether the impaired development of Ly6C þ macrophages in these mice ameliorates colitis. On day 6 of the DSS challenge, the colon tended to be longer in Stat1 À / À than in control mice ( Figure 3a) . Compared with control mice, Stat1 À / À mice showed milder crypt destruction, less goblet-cell loss, and less confluence of inflammatory cell infiltration in the submucosa of the colon, although these parameters were comparable in the two strains before DSS challenge (Figure 3b,c) . Thus, the impaired development of inflammatory macrophages correlated well with the milder colitis observed in Stat1 À / À mice, implying that the Stat1-dependent development of inflammatory macrophages promotes the pathology of colitis.
Maintenance of newly generated inflammatory macrophages by IFN-c
We next examined the role of IFN-g in maintaining inflammatory macrophages in the colon of DSS-challenged mice. Monocytes were isolated from Cx3cr1-gfp knock-in mice after 6 days of DSS challenge, and CX3CR1-GFP þ monocytes were adoptively transferred into DSS-challenged WT recipients (see Methods for details). At 20 h after the transfer, the inflammatory monocytes had given rise to MHC-II þ inflammatory macrophages. However, 30 h after transfer, the inflammatory macrophages began to lose their Ly6C expression, and, by 40 h after transfer, had further converted into migrant macrophages that did not express MMR. We also transferred CX3CR1-GFP ± monocytes into noninflamed WT recipients. At 40 h after the transfer, when MHC-II þ Ly6C þ macrophages were present in the inflamed host, most of the monocytes became MHC-II þ Ly6C À macrophages expressing higher level of CX3CR1 (CX3CR1 high ), one of the representative markers for resident macrophages, in the noninflamed host (Supplementary Figure S3A, B) . This observation was consistent with previous reports demonstrating that it is difficult for inflammatory monocytes to differentiate into resident macrophages in the inflammatory setting. 12, 18 To explore the role of IFN-g, a 1:1 mixture of CX3CR1-GFP þ Ifngr1 À / À monocytes (CD45.2) and WT CX3CR1-GFP þ monocytes (CD45.1) was transferred into WT recipients (CD45.2) on day 4 of the DSS challenge (Figure 4) . At 30 h after the transfer, B80% of the inflammatory macrophages (P2) were of WT monocyte origin. In contrast, the inflammatory monocytes (P1) were composed of a 1:1 mixture of Ifngr1
and WT monocytes, indicating that intrinsic IFN-g signaling is required to maintain newly generated inflammatory macrophages, rather than the migration of monocytes into the inflamed colon. Supporting this notion, the proportion of Ifngr1 À / À monocyte-derived migrant/resident macrophages (P3 and P4) was higher than that of Ifngr1 À / À monocytederived inflammatory macrophages (P2). Collectively, these results indicated that intrinsic IFN-g signaling is important for the maintenance of inflammatory macrophages in the inflamed colon.
It was recently suggested that IFN-g from natural killer (NK) cells is crucial for educating monocytes to acquire an antiinflammatory function in an infection-induced colitis model. 23 The action of IFN-g can be evaluated by the upregulation of Sca-1, a representative IFN-inducible protein, in monocytes and their c-MoP progenitors in the bone marrow. However, in our experimental setting (the DSS-induced colitis model), Sca-1 was not upregulated on bone marrow monocytes (Supplementary Figure S4) . Collectively, these results suggest that IFN-g helps to maintain the colitogenic macrophages generated from monocytes in the inflamed colon, rather than educating monocytes in the bone marrow that will later be recruited to the colon. In our experimental setting, the cell types that produce IFN-g in the inflamed colon have not been identified. In general, T helper type 1 cells and NK cells are major producers of IFN-g. However, depleting these cell types by administrating GK1.5 and PK136 monoclonal antibodies did not affect the development of colitogenic macrophages (data not shown), and various cell types produced IFN-g, including CD4, CD8, CD3 þ NK1.1 þ NKT-like cells, NKp46 þ ILC1-like cells, and 
CD3
À CD4 þ LTi-like cells (Supplementary Figure S5) , as previously reported. 24 
Increased colitogenic-mediator gene transcription by IFN-c through histone acetylation
We next sought to elucidate the mechanisms by which IFN-g regulates TNF and iNOS in the monocyte/macrophage lineage in the inflamed colon. Commensal bacteria and their products, including Toll-like receptor ligands, trigger inflammatory responses by macrophages, and these inflammatory responses are associated with IBD pathology. Specifically deleting MyD88 in macrophages attenuates the severity of colitis in IL-10-deficient mice. 25 In this context, effective Toll-like receptor signaling is necessary for chromatin remodeling, including acetylation, to transcribe DNA. [26] [27] [28] Thus, we hypothesized that IFN-g regulates the gene expression of inflammatory mediators through histone acetylation to promote colitogenicity. To test this hypothesis, we assayed the mRNA levels of inflammatory mediators in the colitogenic cells (P1 þ P2) sorted from the colon of steady-state mice (steady state) and the inflamed colon of mice treated with either a control antibody (isotype) or the neutralizing anti-IFN-g antibody, XMG1.2 ( Figure 5a) . Strikingly, the mRNA levels of colitogenic mediators such as Tnf and Nos2 were dramatically increased upon colitis induction and decreased by treatment with the neutralizing anti-IFN-g antibody, whereas Il6 was not affected. Anti-IFN-g treatment also reduced the Stat1 expression. Similar results were obtained using Stat1 À / À mice (Supplementary Figure S6) , suggesting that the IFN-g-Stat1 axis is essential for the induction of colitogenic mediators from the colitogenic cells in the inflamed colon.
To test whether IFN-g enhances the transcription of colitismediating genes via histone acetylation, we performed chromatin immunoprecipitation (ChIP) assays using antibodies against acetyl-histone 4. ChIP-quantitative PCR revealed that the acetylation was elevated at the promoter regions for Tnf and Nos2 but not Il6 in the colitogenic cells isolated from the inflamed colon of DSS-treated mice (Figure 5b) . Remarkably, the histone acetylation status was canceled by IFN-g neutralization in vivo (Figure 5b) , showing that IFN-g signaling is essential for histone acetylation in the promoter region of colitis-mediating genes. The transcription factor p65, also known as RELA, is involved in forming nuclear factor (NF)-kB heterodimers and activating inflammatory cytokine genes. 29 Thus, we investigated the p65 activation (Figure 5c ). Phosphorylated p65 was increased upon DSS challenge and remained elevated despite treatment with a neutralizing anti-IFN-g antibody, suggesting that IFN-g is dispensable for p65 activation. In line with these results, IFN-g minimally affected the Toll-like receptor signaling in macrophages upon lipopolysaccharide stimulation in vitro. 30 Collectively, our results show that IFN-g induces genes that encode colitis mediators via histone modification, causing macrophages in the inflamed colon to produce these inflammatory mediators.
DISCUSSION
In this study, we showed that CD64 þ cells in the inflamed colon are divided into four major subpopulations, namely inflammatory monocytes, inflammatory macrophages, migrant macrophages, and resident macrophages. Among these subpopulations, we identified the former two as highly colitogenic populations that produce colitis-associated inflammatory mediators such as TNF and iNOS. In this context, the generation of inflammatory macrophages from inflammatory monocytes depended on IFN-g-Stat1 signaling. This mechanism may account for the previous observation that IFN-g À / À mice are resistant to DSS colitis. 31 Our findings also showed that IFN-g instructs the development of the colitogenic monocyte/macrophage lineage in response to DSS challenge in vivo by epigenetically controlling the transcription of inflammatory mediators via the transcription factor STAT1. Supporting these findings, an in vitro study using human macrophages revealed that IFN-g induces STAT1 and IRF1 occupancy and histone acetylation at the promoter region of the Tnf, Il6, and Il12b genes, 30 thus increasing the transcription of these cytokines in response to lipopolysaccharide stimulation. We observed defects in the development of colitogenic macrophages in both Ifngr1
À / À and Stat1
mice, and showed that the IFN-g-Stat1 axis is essential for histone acetylation at the loci of colitogenic mediators such as Tnf and Nos2 in the colonic monocyte/macrophage lineage of DSS-injected mice. These results suggested that the IFN-gStat1 pathway affects both the differentiation of inflammatory monocytes into inflammatory macrophages and the transcription of inflammatory genes in these cells. Deacetylase inhibitor trichostatin A or butyrate suppresses the transcription of inflammatory genes such as Nos2 and Il6 in colonic macrophages in the steady state. However, in vivo butyrate treatment did not affect the severity of DSS-induced colitis, 32 implying that different mechanisms regulate gene expression in the steady state vs. the inflammatory environment. Based on existing literature and our present findings, inhibiting acetyl transferase rather than deacetylase might more effectively improve IBD symptoms by regulating the colitogenic monocyte/macrophage lineage.
We note that the reduction in P2 cells was relatively modest in the inflamed colon of Ifngr1 À / À and Stat1 À / À mice. However, the susceptibility of colitis is affected not only by the frequencies but also by the colitogenic properties of the P1 and P2 cells. Indeed, the expression levels of Tnfa and Nos2 were significantly reduced in these cells in WT mice treated with XMG1.2 (an anti-IFNg neutralizing antibody) and in Stat1 À / À mice ( Figure 5a and Supplementary Figure S6 ) that would substantially contribute to the improvement of colitis.
Overall, our findings present the education mechanism for colitogenic macrophages during their local differentiation from monocytes. The origin and fate of colon macrophages in the steady state and in an inflammatory context are well studied, 12, 18 but the mechanism (including the master transcriptional regulator) by which macrophages acquire colitogenicity in vivo has not been fully clarified. Addressing this issue, our study revealed that the IFN-g-Stat1 pathway plays a critical role in generating colitogenic macrophages by promoting transcription of the Tnf and Nos2 genes via histone acetylation. In addition to these epigenetic changes, a recent study showed that IFN-g selectively modulates macrophage translatomes to promote inflammation, to further reprogram metabolic pathways, and to regulate protein synthesis after Toll-like receptor-2 stimulation in vitro. 33 Epigenetic reprogramming, signaling pathways, and metabolic processes are all known to mediate macrophage training. 34, 35 By identifying the colitogenic monocyte and macrophage subsets and their induction machinery, our study may provide new therapeutic targets for IBD and colon cancer.
METHODS
Mice and DSS induction of colitis
We obtained C57BL/6 (B6) mice from SLC Japan (Shizuoka, Japan), B6.SJL-ptprca (B6.SJL) mice congenic at the CD45 locus (CD45.1 þ CD45.2 À ) from Taconic (Rensselaer, NY), and B6.Stat1
À / À , B6.Ifngr1 À / À , and Cx3cr1-gfp mice from Jackson Laboratory (Bar Harbor, ME). Mice were kept 5-6/cage under specific-pathogen-free conditions using the Micro-VENT system (Allentown, PA) and were maintained on sterile chow. All of the animal experiments were approved by the Institutional Animal Care Committee of Tokyo Medical and Dental University. Mice were given 2% (wt/vol) DSS (MP Biochemicals, Santa Ana, CA) in the drinking water for 6-7 days. In some experiments, WT hosts received a neutralizing anti-IFN-g antibody (400 mg/ per mouse) (Bio X cells, West Lebanon, MA).
Intestinal cell preparation and flow cytometry
Colonic lamina propria cells were isolated as previously described. 13 The colon was opened, washed with phosphate-buffered saline (PBS), cut into segments, and shaken in PBS containing 5 mM EDTA. The tissue was thoroughly washed in PBS to remove residual epithelial cells, cut into tiny pieces with scissors, and digested by shaking in PBS containing 0.1% type IV collagenase (Sigma-Aldrich, St Louis, MO) for 30 min at 37 1C. The cells were filtered through a 100 mm cell strainer, washed in 1% fetal calf serum-PBS, and stained with a combination of anti-CD11c (N418), anti-CD11b (M1/70), anti-I-A/I-E (M5/114.15.2), anti-CD64 (X54-5/7.1), anti-CD45 (30-F11), anti-CD45.1 (A20), anti-Ly6C (HK1.4), anti-Ly6G (1A8), anti-CD3 (145-2C11), anti-CD19 (6D5), anti-NK1.1 (PK136), anti-Ter119 (TER119), anti-CCR2 (475301), and 7-aminoactinomycin D after blocking Fc receptors. Antibodies were obtained from Biolegend (San Diego, CA), BD Pharmingen (San Diego, CA), or R&D System (Minneapolis, MN). Flow cytometry and sorting was performed on a FACSAria III (BD Biosciences, San Diego, CA). FlowJo software (Tree Star, Ashland, OR) was used for data analysis.
Adoptive transfer of bone marrow monocytes
Bone marrow was flushed from the tibias and femurs of donor Cx3cr1-gfp knock-in mice that had been challenged with DSS for 6 days to activate and expand monocytes. After lysing red blood cells with ACK lysing buffer, the cells were stained with phycoerythrin/Cy5-or Alexa-647-conjugated antibodies against CD3, CD19, NK1.1, Ter119, I-A/I-E, B220, and Ly6G. Lineage-marker-positive cells were depleted with anti-Cy5/Alexa-647 microbeads and an AutoMACSpro separation system (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturers' instructions. Cx3cr1 int , c-kit À , CD11c À , and SSC low monocytes were then sorted with a FACSAria III. The purified monocytes were transferred intravenously into the tail vein of WT hosts (CD45.1 À CD45.2 þ ) 4 days after the start of DSS treatment. After transferring, the host colons were analyzed at various time points.
Cytokine measurement in colonic tissue
Tissue from the distal colon was cut into 1 cm segments, homogenized with scissors, and suspended in 500 ml Hanks' balanced salt solution containing 0.1% Triton X-100 and protease and phosphatase inhibitors. Supernatants were collected by centrifugation (10,000 r.p.m., 5 min) and assessed for IFN-g (eBioscience, San Diego, CA).
NF-jB p65 measurement
Total and phosphorylated NF-kB p65 were assayed by enzymelinked immunosorbent assay (ELISA) using the InstantOne ELISA Kit (eBioscience).
Histological analysis
Tissue harvested from the distal colon was cut into segments, fixed with 10% Formaldehyde Neutral Buffer Solution (Nacalai, Kyoto, Japan) overnight, embedded in paraffin, sectioned at 5 mm, and stained with hematoxylin and eosin. Histological scores were evaluated as described previously. 36 The severity of inflammation was graded from 0 to 3 as follows: 0, rare inflammatory cells in the lamina propria; 1, increased inflammatory cells in the lamina propria; 2, confluent inflammatory cells extending into the submucosa; and 3, the transmural extension of inflammatory cell infiltrate. Damage was graded from 0 to 4 as follows: 0, none; 1, loss of the basal 1/3 of the crypt; 2, loss of the basal 2/3 of the crypt; 3, loss of the entire crypt but with intact epithelial cells; and 4; loss of the entire crypt and the surface epithelial cells.
Quantitative reverse transcription-PCR
To measure mRNA expression, total RNA was extracted from sorted macrophages using the RNeasy Mini Kit (Qiagen, Hilden, Germany), and complementary DNA was synthesized using random hexamers and SuperScript III Reverse Transcriptase (Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. Quantitative PCR was performed with a LightCycler 480 Sybr Green I (Roche, Penzbarg, Germany). Primer pairs for each sequence are listed in Supplementary Table S1 . Relative expression was normalized to Gapdh. Data are represented as the fold induction over the day-0 total for CD64 þ MHC-II þ macrophages.
ChIP assay
ChIP assays were performed as described previously 37 with minor modifications: 10 5 colon macrophages were fixed with 1% formaldehyde for 10 min to obtain crosslinked chromatins. Cells were washed with cold PBS, solubilized with SDS lysis buffer containing protease inhibitors, and sonicated to obtain DNA fragments. After centrifuging, the supernatants were diluted 10-fold in ChIP dilution buffer and immunoprecipitated with antibodies against acetyl histone 4 (Merck Millipore, Darmstadt, Germany) and with salmon sperm DNA/proteinase A-agarose (Merck Millipore). The immunoprecipitated chromatins were washed, eluted, and incubated at 65 1C to reverse the crosslinks. After treatment with proteinase K, the recovered DNA was purified with ChIP DNA Clean & Concentrator (Zymo Research, Irvine, CA), and analyzed by qPCR using gene-specific primers (Supplementary Table S2 ).
Statistical analysis
Normally distributed, continuous variables were compared by two-tailed unpaired t-tests and one-way analysis of variance followed by Tukey's post comparison, using Prism software.
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